1997
DOI: 10.1016/s0960-894x(97)10136-6
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and membrane permeability of PNA-peptide conjugates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
68
0

Year Published

1998
1998
2011
2011

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 99 publications
(70 citation statements)
references
References 17 publications
2
68
0
Order By: Relevance
“…Furthermore, PNA/DNA chimeras [48] [49], PNApeptide conjugates [50] [51], and PNA conjugates to high-molecular weight PEG [52] or polyethyleneimine [53] were developed. Typically, these methods involve the introduction of additional reaction sites and/or stereogenic centers inducing preferred helical orientations [42].…”
Section: Solubility Enhancermentioning
confidence: 99%
“…Furthermore, PNA/DNA chimeras [48] [49], PNApeptide conjugates [50] [51], and PNA conjugates to high-molecular weight PEG [52] or polyethyleneimine [53] were developed. Typically, these methods involve the introduction of additional reaction sites and/or stereogenic centers inducing preferred helical orientations [42].…”
Section: Solubility Enhancermentioning
confidence: 99%
“…10,11 Through deletion studies it was shown that uptake of these proteins is mediated by small regions of each protein, less than 30 amino acids in size, known as cell penetrating peptides (CPPs). These sequences can also mediate uptake of attached cargoes, including low molecular weight drugs, 12 proteins, 13 nucleic acids 14 and peptides. 15 CPPs have diverse sequences and structures and studies on their uptake show that internalization can occur by different mechanisms-possibly even simultaneously-including clathrindependent endocytosis, 16 lipid raft-mediated macropinocytosis, 17 clathrin-and caveolin-independent endocytosis 18 and direct membrane penetration.…”
Section: E Ffectors Are Pathogen-encoded Proteins That Are Thought Tomentioning
confidence: 99%
“…The PNA inhibitors used in these studies are both potent and selective. Methods have recently been described that allow spontaneous uptake of PNAs into mammalian cells (Simmons et al, 1997;Pooga et al, 1998), and permit targeting to intracellular mRNA species (Pooga et al, 1998), suggesting that PNAs may themselves be useful lead compounds for therapy. In addition, 2'-O-meRNA oligonucleotides, a type of oligomer already being used in clinical trials, have also been shown to be eective in vitro inhibitors of strand elongation by telomerase (Pitts and Corey, 1998).…”
Section: Conclusion and Future Prospectsmentioning
confidence: 99%